We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Acrongenomics Appoints President and Vice President

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Acrongenomics, Inc. has announced the appointment of Mr. Constantine Poulios, LL.M., as President. Mr. Poulios was holding the position of Vice President at Acrongenomics Inc. as of July 6, 2004.

Mr. Poulios succeeds Dr. Eleftherios Georgakopoulos, who retired from the board earlier this week.

The leadership change coincides with the transfer of the former president's 4 million shares to the treasury of the company, while the company keeps full title on all its technology developed to date.

Mr. Poulios has extensive experience in serving multinational companies. An attorney by education and profession, he was part of the Corporate and Tax Advisory Services of Ernst & Young before joining Acrongenomics, Inc.

Mr. Poulios was managing important accounts including that of Coca Cola, Halliburton, Hewlett Packard, ABN AMRO, Citigroup, Ciments Francais, PfizerGlaxoSmithKline and EMI Music for Ernst & Young Southeast Europe, while he has also worked for Ernst & Young in the US.

He obtained his Master's of Laws from Northwestern University School of Law in Chicago in 1997, while he is a 1995 graduate from the School of Law at the National University of Athens.

Mr. Poulios has also been awarded with a Certificate in Law in 1993 from the School of Law at the University of Bordeaux in France and he has attended graduate courses in management in US universities.

As a corporate executive who has driven business initiative of global corporations for some years, Mr. Poulios is looking forward to bringing in apart from his skills and his business and legal expertise, hands-on knowledge on how to properly conduct business in the rigorous environment of the Sarbanes-Oxley legislation.

Acrongenomics, Inc. has also announced the appointment of Mr. Platon Tzouvalis, MSc. as Vice President.

As a Biochemist, Mr. Tzouvalis is an experienced pharmaceutical industry professional. He has been a member of Acrongenomics' Scientific Advisory Board since May 2004.

His expertise lies in the areas of Quality Control, Operational Procedures as well as Pharmaceutical Product and Process Improvement.

He received his B.S. Degree in Biochemistry from the University of Illinois in 1990 and his Master's Degree in the same field from DePaul University at Chicago in 1995.

Mr. Tzouvalis' earlier career includes working as a Research Chemist in collaboration with the University of Illinois at Chicago, holding the position of Research and Development Chemist at SynQuest, Inc. and as Advanced Quality Assurance Specialist of Organic Operations and then Project Manager in Bioanalytical Quality Assurance for Abbott Laboratories

Mr. Tzouvalis has also been awarded with the Abbott Diagnostics Division Science Award of 2002 as part of the Organic Operation Remediation Team.